Oral Proteins and Peptides Market - Global Outlook and Forecast 2021-2027

Oral Proteins and Peptides Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Oral Proteins and Peptides Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oral Proteins and Peptides Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oral Proteins and Peptides Overall Market Size
2.1 Global Oral Proteins and Peptides Market Size: 2021 VS 2027
2.2 Global Oral Proteins and Peptides Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Oral Proteins and Peptides Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Oral Proteins and Peptides Players in Global Market
3.2 Top Global Oral Proteins and Peptides Companies Ranked by Revenue
3.3 Global Oral Proteins and Peptides Revenue by Companies
3.4 Global Oral Proteins and Peptides Sales by Companies
3.5 Global Oral Proteins and Peptides Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Oral Proteins and Peptides Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Oral Proteins and Peptides Product Type
3.8 Tier 1, Tier 2 and Tier 3 Oral Proteins and Peptides Players in Global Market
3.8.1 List of Global Tier 1 Oral Proteins and Peptides Companies
3.8.2 List of Global Tier 2 and Tier 3 Oral Proteins and Peptides Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Oral Proteins and Peptides Market Size Markets, 2021 & 2027
4.1.2 Linaclotide
4.1.3 Calcitonin
4.1.4 Insulin
4.1.5 Octreotide
4.2 By Type - Global Oral Proteins and Peptides Revenue & Forecasts
4.2.1 By Type - Global Oral Proteins and Peptides Revenue, 2016-2021
4.2.2 By Type - Global Oral Proteins and Peptides Revenue, 2022-2027
4.2.3 By Type - Global Oral Proteins and Peptides Revenue Market Share, 2016-2027
4.3 By Type - Global Oral Proteins and Peptides Sales & Forecasts
4.3.1 By Type - Global Oral Proteins and Peptides Sales, 2016-2021
4.3.2 By Type - Global Oral Proteins and Peptides Sales, 2022-2027
4.3.3 By Type - Global Oral Proteins and Peptides Sales Market Share, 2016-2027
4.4 By Type - Global Oral Proteins and Peptides Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Oral Proteins and Peptides Market Size, 2021 & 2027
5.1.2 Gastric & Digestive Disorders
5.1.3 Bone Diseases
5.1.4 Diabetes
5.1.5 Hormonal Disorders
5.2 By Application - Global Oral Proteins and Peptides Revenue & Forecasts
5.2.1 By Application - Global Oral Proteins and Peptides Revenue, 2016-2021
5.2.2 By Application - Global Oral Proteins and Peptides Revenue, 2022-2027
5.2.3 By Application - Global Oral Proteins and Peptides Revenue Market Share, 2016-2027
5.3 By Application - Global Oral Proteins and Peptides Sales & Forecasts
5.3.1 By Application - Global Oral Proteins and Peptides Sales, 2016-2021
5.3.2 By Application - Global Oral Proteins and Peptides Sales, 2022-2027
5.3.3 By Application - Global Oral Proteins and Peptides Sales Market Share, 2016-2027
5.4 By Application - Global Oral Proteins and Peptides Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Oral Proteins and Peptides Market Size, 2021 & 2027
6.2 By Region - Global Oral Proteins and Peptides Revenue & Forecasts
6.2.1 By Region - Global Oral Proteins and Peptides Revenue, 2016-2021
6.2.2 By Region - Global Oral Proteins and Peptides Revenue, 2022-2027
6.2.3 By Region - Global Oral Proteins and Peptides Revenue Market Share, 2016-2027
6.3 By Region - Global Oral Proteins and Peptides Sales & Forecasts
6.3.1 By Region - Global Oral Proteins and Peptides Sales, 2016-2021
6.3.2 By Region - Global Oral Proteins and Peptides Sales, 2022-2027
6.3.3 By Region - Global Oral Proteins and Peptides Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Oral Proteins and Peptides Revenue, 2016-2027
6.4.2 By Country - North America Oral Proteins and Peptides Sales, 2016-2027
6.4.3 US Oral Proteins and Peptides Market Size, 2016-2027
6.4.4 Canada Oral Proteins and Peptides Market Size, 2016-2027
6.4.5 Mexico Oral Proteins and Peptides Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Oral Proteins and Peptides Revenue, 2016-2027
6.5.2 By Country - Europe Oral Proteins and Peptides Sales, 2016-2027
6.5.3 Germany Oral Proteins and Peptides Market Size, 2016-2027
6.5.4 France Oral Proteins and Peptides Market Size, 2016-2027
6.5.5 U.K. Oral Proteins and Peptides Market Size, 2016-2027
6.5.6 Italy Oral Proteins and Peptides Market Size, 2016-2027
6.5.7 Russia Oral Proteins and Peptides Market Size, 2016-2027
6.5.8 Nordic Countries Oral Proteins and Peptides Market Size, 2016-2027
6.5.9 Benelux Oral Proteins and Peptides Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Oral Proteins and Peptides Revenue, 2016-2027
6.6.2 By Region - Asia Oral Proteins and Peptides Sales, 2016-2027
6.6.3 China Oral Proteins and Peptides Market Size, 2016-2027
6.6.4 Japan Oral Proteins and Peptides Market Size, 2016-2027
6.6.5 South Korea Oral Proteins and Peptides Market Size, 2016-2027
6.6.6 Southeast Asia Oral Proteins and Peptides Market Size, 2016-2027
6.6.7 India Oral Proteins and Peptides Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Oral Proteins and Peptides Revenue, 2016-2027
6.7.2 By Country - South America Oral Proteins and Peptides Sales, 2016-2027
6.7.3 Brazil Oral Proteins and Peptides Market Size, 2016-2027
6.7.4 Argentina Oral Proteins and Peptides Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Oral Proteins and Peptides Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Oral Proteins and Peptides Sales, 2016-2027
6.8.3 Turkey Oral Proteins and Peptides Market Size, 2016-2027
6.8.4 Israel Oral Proteins and Peptides Market Size, 2016-2027
6.8.5 Saudi Arabia Oral Proteins and Peptides Market Size, 2016-2027
6.8.6 UAE Oral Proteins and Peptides Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Allergan
7.1.1 Allergan Corporate Summary
7.1.2 Allergan Business Overview
7.1.3 Allergan Oral Proteins and Peptides Major Product Offerings
7.1.4 Allergan Oral Proteins and Peptides Sales and Revenue in Global (2016-2021)
7.1.5 Allergan Key News
7.2 AstraZeneca
7.2.1 AstraZeneca Corporate Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Oral Proteins and Peptides Major Product Offerings
7.2.4 AstraZeneca Oral Proteins and Peptides Sales and Revenue in Global (2016-2021)
7.2.5 AstraZeneca Key News
7.3 Biocon
7.3.1 Biocon Corporate Summary
7.3.2 Biocon Business Overview
7.3.3 Biocon Oral Proteins and Peptides Major Product Offerings
7.3.4 Biocon Oral Proteins and Peptides Sales and Revenue in Global (2016-2021)
7.3.5 Biocon Key News
7.4 Generex Biotechnology
7.4.1 Generex Biotechnology Corporate Summary
7.4.2 Generex Biotechnology Business Overview
7.4.3 Generex Biotechnology Oral Proteins and Peptides Major Product Offerings
7.4.4 Generex Biotechnology Oral Proteins and Peptides Sales and Revenue in Global (2016-2021)
7.4.5 Generex Biotechnology Key News
7.5 Novo Nordisk
7.5.1 Novo Nordisk Corporate Summary
7.5.2 Novo Nordisk Business Overview
7.5.3 Novo Nordisk Oral Proteins and Peptides Major Product Offerings
7.5.4 Novo Nordisk Oral Proteins and Peptides Sales and Revenue in Global (2016-2021)
7.5.5 Novo Nordisk Key News
7.6 Synergy Pharmaceuticals
7.6.1 Synergy Pharmaceuticals Corporate Summary
7.6.2 Synergy Pharmaceuticals Business Overview
7.6.3 Synergy Pharmaceuticals Oral Proteins and Peptides Major Product Offerings
7.6.4 Synergy Pharmaceuticals Oral Proteins and Peptides Sales and Revenue in Global (2016-2021)
7.6.5 Synergy Pharmaceuticals Key News
7.7 Tarsa Therapeutics
7.7.1 Tarsa Therapeutics Corporate Summary
7.7.2 Tarsa Therapeutics Business Overview
7.7.3 Tarsa Therapeutics Oral Proteins and Peptides Major Product Offerings
7.4.4 Tarsa Therapeutics Oral Proteins and Peptides Sales and Revenue in Global (2016-2021)
7.7.5 Tarsa Therapeutics Key News
7.8 Sanofi
7.8.1 Sanofi Corporate Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Oral Proteins and Peptides Major Product Offerings
7.8.4 Sanofi Oral Proteins and Peptides Sales and Revenue in Global (2016-2021)
7.8.5 Sanofi Key News
7.9 Hoffmann-La Roche
7.9.1 Hoffmann-La Roche Corporate Summary
7.9.2 Hoffmann-La Roche Business Overview
7.9.3 Hoffmann-La Roche Oral Proteins and Peptides Major Product Offerings
7.9.4 Hoffmann-La Roche Oral Proteins and Peptides Sales and Revenue in Global (2016-2021)
7.9.5 Hoffmann-La Roche Key News
7.10 Synthetic Biologics
7.10.1 Synthetic Biologics Corporate Summary
7.10.2 Synthetic Biologics Business Overview
7.10.3 Synthetic Biologics Oral Proteins and Peptides Major Product Offerings
7.10.4 Synthetic Biologics Oral Proteins and Peptides Sales and Revenue in Global (2016-2021)
7.10.5 Synthetic Biologics Key News
7.11 Hovione
7.11.1 Hovione Corporate Summary
7.11.2 Hovione Oral Proteins and Peptides Business Overview
7.11.3 Hovione Oral Proteins and Peptides Major Product Offerings
7.11.4 Hovione Oral Proteins and Peptides Sales and Revenue in Global (2016-2021)
7.11.5 Hovione Key News
7.12 Novartis
7.12.1 Novartis Corporate Summary
7.12.2 Novartis Oral Proteins and Peptides Business Overview
7.12.3 Novartis Oral Proteins and Peptides Major Product Offerings
7.12.4 Novartis Oral Proteins and Peptides Sales and Revenue in Global (2016-2021)
7.12.5 Novartis Key News
8 Global Oral Proteins and Peptides Production Capacity, Analysis
8.1 Global Oral Proteins and Peptides Production Capacity, 2016-2027
8.2 Oral Proteins and Peptides Production Capacity of Key Manufacturers in Global Market
8.3 Global Oral Proteins and Peptides Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Oral Proteins and Peptides Supply Chain Analysis
10.1 Oral Proteins and Peptides Industry Value Chain
10.2 Oral Proteins and Peptides Upstream Market
10.3 Oral Proteins and Peptides Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Oral Proteins and Peptides Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Oral Proteins and Peptides in Global Market
Table 2. Top Oral Proteins and Peptides Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Oral Proteins and Peptides Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Oral Proteins and Peptides Revenue Share by Companies, 2016-2021
Table 5. Global Oral Proteins and Peptides Sales by Companies, (K MT), 2016-2021
Table 6. Global Oral Proteins and Peptides Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Oral Proteins and Peptides Price (2016-2021) & (USD/MT)
Table 8. Global Manufacturers Oral Proteins and Peptides Product Type
Table 9. List of Global Tier 1 Oral Proteins and Peptides Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oral Proteins and Peptides Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Oral Proteins and Peptides Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Oral Proteins and Peptides Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Oral Proteins and Peptides Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Oral Proteins and Peptides Sales (K MT), 2016-2021
Table 15. By Type - Global Oral Proteins and Peptides Sales (K MT), 2022-2027
Table 16. By Application - Global Oral Proteins and Peptides Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Oral Proteins and Peptides Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Oral Proteins and Peptides Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Oral Proteins and Peptides Sales (K MT), 2016-2021
Table 20. By Application - Global Oral Proteins and Peptides Sales (K MT), 2022-2027
Table 21. By Region - Global Oral Proteins and Peptides Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Oral Proteins and Peptides Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Oral Proteins and Peptides Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Oral Proteins and Peptides Sales (K MT), 2016-2021
Table 25. By Region - Global Oral Proteins and Peptides Sales (K MT), 2022-2027
Table 26. By Country - North America Oral Proteins and Peptides Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Oral Proteins and Peptides Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Oral Proteins and Peptides Sales, (K MT), 2016-2021
Table 29. By Country - North America Oral Proteins and Peptides Sales, (K MT), 2022-2027
Table 30. By Country - Europe Oral Proteins and Peptides Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Oral Proteins and Peptides Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Oral Proteins and Peptides Sales, (K MT), 2016-2021
Table 33. By Country - Europe Oral Proteins and Peptides Sales, (K MT), 2022-2027
Table 34. By Region - Asia Oral Proteins and Peptides Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Oral Proteins and Peptides Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Oral Proteins and Peptides Sales, (K MT), 2016-2021
Table 37. By Region - Asia Oral Proteins and Peptides Sales, (K MT), 2022-2027
Table 38. By Country - South America Oral Proteins and Peptides Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Oral Proteins and Peptides Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Oral Proteins and Peptides Sales, (K MT), 2016-2021
Table 41. By Country - South America Oral Proteins and Peptides Sales, (K MT), 2022-2027
Table 42. By Country - Middle East & Africa Oral Proteins and Peptides Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Oral Proteins and Peptides Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Oral Proteins and Peptides Sales, (K MT), 2016-2021
Table 45. By Country - Middle East & Africa Oral Proteins and Peptides Sales, (K MT), 2022-2027
Table 46. Allergan Corporate Summary
Table 47. Allergan Oral Proteins and Peptides Product Offerings
Table 48. Allergan Oral Proteins and Peptides Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 49. AstraZeneca Corporate Summary
Table 50. AstraZeneca Oral Proteins and Peptides Product Offerings
Table 51. AstraZeneca Oral Proteins and Peptides Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 52. Biocon Corporate Summary
Table 53. Biocon Oral Proteins and Peptides Product Offerings
Table 54. Biocon Oral Proteins and Peptides Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 55. Generex Biotechnology Corporate Summary
Table 56. Generex Biotechnology Oral Proteins and Peptides Product Offerings
Table 57. Generex Biotechnology Oral Proteins and Peptides Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 58. Novo Nordisk Corporate Summary
Table 59. Novo Nordisk Oral Proteins and Peptides Product Offerings
Table 60. Novo Nordisk Oral Proteins and Peptides Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 61. Synergy Pharmaceuticals Corporate Summary
Table 62. Synergy Pharmaceuticals Oral Proteins and Peptides Product Offerings
Table 63. Synergy Pharmaceuticals Oral Proteins and Peptides Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 64. Tarsa Therapeutics Corporate Summary
Table 65. Tarsa Therapeutics Oral Proteins and Peptides Product Offerings
Table 66. Tarsa Therapeutics Oral Proteins and Peptides Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 67. Sanofi Corporate Summary
Table 68. Sanofi Oral Proteins and Peptides Product Offerings
Table 69. Sanofi Oral Proteins and Peptides Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 70. Hoffmann-La Roche Corporate Summary
Table 71. Hoffmann-La Roche Oral Proteins and Peptides Product Offerings
Table 72. Hoffmann-La Roche Oral Proteins and Peptides Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 73. Synthetic Biologics Corporate Summary
Table 74. Synthetic Biologics Oral Proteins and Peptides Product Offerings
Table 75. Synthetic Biologics Oral Proteins and Peptides Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 76. Hovione Corporate Summary
Table 77. Hovione Oral Proteins and Peptides Product Offerings
Table 78. Hovione Oral Proteins and Peptides Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 79. Novartis Corporate Summary
Table 80. Novartis Oral Proteins and Peptides Product Offerings
Table 81. Novartis Oral Proteins and Peptides Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 82. Oral Proteins and Peptides Production Capacity (K MT) of Key Manufacturers in Global Market, 2019-2021 (K MT)
Table 83. Global Oral Proteins and Peptides Capacity Market Share of Key Manufacturers, 2019-2021
Table 84. Global Oral Proteins and Peptides Production by Region, 2016-2021 (K MT)
Table 85. Global Oral Proteins and Peptides Production by Region, 2022-2027 (K MT)
Table 86. Oral Proteins and Peptides Market Opportunities & Trends in Global Market
Table 87. Oral Proteins and Peptides Market Drivers in Global Market
Table 88. Oral Proteins and Peptides Market Restraints in Global Market
Table 89. Oral Proteins and Peptides Raw Materials
Table 90. Oral Proteins and Peptides Raw Materials Suppliers in Global Market
Table 91. Typical Oral Proteins and Peptides Downstream
Table 92. Oral Proteins and Peptides Downstream Clients in Global Market
Table 93. Oral Proteins and Peptides Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Oral Proteins and Peptides Segment by Type
Figure 2. Oral Proteins and Peptides Segment by Application
Figure 3. Global Oral Proteins and Peptides Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Oral Proteins and Peptides Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Oral Proteins and Peptides Revenue, 2016-2027 (US$, Mn)
Figure 7. Oral Proteins and Peptides Sales in Global Market: 2016-2027 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Oral Proteins and Peptides Revenue in 2020
Figure 9. By Type - Global Oral Proteins and Peptides Sales Market Share, 2016-2027
Figure 10. By Type - Global Oral Proteins and Peptides Revenue Market Share, 2016-2027
Figure 11. By Type - Global Oral Proteins and Peptides Price (USD/MT), 2016-2027
Figure 12. By Application - Global Oral Proteins and Peptides Sales Market Share, 2016-2027
Figure 13. By Application - Global Oral Proteins and Peptides Revenue Market Share, 2016-2027
Figure 14. By Application - Global Oral Proteins and Peptides Price (USD/MT), 2016-2027
Figure 15. By Region - Global Oral Proteins and Peptides Sales Market Share, 2016-2027
Figure 16. By Region - Global Oral Proteins and Peptides Revenue Market Share, 2016-2027
Figure 17. By Country - North America Oral Proteins and Peptides Revenue Market Share, 2016-2027
Figure 18. By Country - North America Oral Proteins and Peptides Sales Market Share, 2016-2027
Figure 19. US Oral Proteins and Peptides Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Oral Proteins and Peptides Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Oral Proteins and Peptides Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Oral Proteins and Peptides Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Oral Proteins and Peptides Sales Market Share, 2016-2027
Figure 24. Germany Oral Proteins and Peptides Revenue, (US$, Mn), 2016-2027
Figure 25. France Oral Proteins and Peptides Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Oral Proteins and Peptides Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Oral Proteins and Peptides Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Oral Proteins and Peptides Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Oral Proteins and Peptides Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Oral Proteins and Peptides Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Oral Proteins and Peptides Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Oral Proteins and Peptides Sales Market Share, 2016-2027
Figure 33. China Oral Proteins and Peptides Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Oral Proteins and Peptides Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Oral Proteins and Peptides Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Oral Proteins and Peptides Revenue, (US$, Mn), 2016-2027
Figure 37. India Oral Proteins and Peptides Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Oral Proteins and Peptides Revenue Market Share, 2016-2027
Figure 39. By Country - South America Oral Proteins and Peptides Sales Market Share, 2016-2027
Figure 40. Brazil Oral Proteins and Peptides Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Oral Proteins and Peptides Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Oral Proteins and Peptides Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Oral Proteins and Peptides Sales Market Share, 2016-2027
Figure 44. Turkey Oral Proteins and Peptides Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Oral Proteins and Peptides Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Oral Proteins and Peptides Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Oral Proteins and Peptides Revenue, (US$, Mn), 2016-2027
Figure 48. Global Oral Proteins and Peptides Production Capacity (K MT), 2016-2027
Figure 49. The Percentage of Production Oral Proteins and Peptides by Region, 2020 VS 2027
Figure 50. Oral Proteins and Peptides Industry Value Chain
Figure 51. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs